Home/Filings/4/0000899243-21-023881
4//SEC Filing

Woiwode Thomas 4

Accession 0000899243-21-023881

CIK 0001799448other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:43 PM ET

Size

17.0 KB

Accession

0000899243-21-023881

Insider Transaction Report

Form 4
Period: 2021-06-11
Transactions
  • Other

    Common Stock

    2021-06-11485,9791,457,937 total(indirect: See Footnote)
  • Other

    Common Stock

    2021-06-119,7190 total(indirect: See Footnote)
  • Other

    Common Stock

    2021-06-11+8,3838,383 total(indirect: See Footnote)
  • Other

    Common Stock

    2021-06-118,3830 total(indirect: See Footnote)
  • Other

    Common Stock

    2021-06-11+2,2264,452 total
  • Other

    Common Stock

    2021-06-11+9,7199,719 total(indirect: See Footnote)
Holdings
  • Common Stock

    (indirect: See Footnote)
    862,444
Footnotes (10)
  • [F1]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by Versant Venture Capital VI, L.P. ("VVC VI") to its partners pursuant to a Rule 10b5-1 trading plan.
  • [F10]Shares held by Versant Vantage I, L.P. ("VV I"). Versant Vantage I GP, L.P. ("VV I GP") is the general partner of VV I, and Versant Vantage I GP-GP, LLC ("VV I GP-GP") is the general partner of VV I GP. The Reporting Person is a managing member of VV I GP-GP and may be deemed to share voting and dispositive power over the shares held by VV I; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
  • [F2]Shares held by VVC VI. Versant Ventures VI GP, L.P. ("VV VI GP") is the general partner of VVC VI, and Versant Ventures VI GP-GP, LLC ("VV VI GP-GP") is the general partner of VV VI GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held by VVC VI; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
  • [F3]Represents a change in the form of ownership of VV VI GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VVC VI.
  • [F4]Shares held by VV VI GP. VV VI GP-GP is the general partner of VV VI GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held by VV VI GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
  • [F5]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP, to its partners.
  • [F6]Represents a change in the form of ownership of VV VI GP-GP by virtue of the receipt of shares in the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VV VI GP.
  • [F7]Shares held by VV VI GP-GP. The Reporting Person is a managing member of VV VI GP-GP and may be deemed to share voting and dispositive power over the shares held VV VI GP-GP; however, he disclaims beneficial ownership of such securities, except to the extent of his pecuniary interests therein.
  • [F8]Represents a pro-rata distribution, and not a purchase or sale, without additional consideration by VV VI GP-GP, to its members.
  • [F9]Represents a change in the form of ownership of the Reporting Person by virtue of the receipt of shares as a result of the pro-rata in-kind distribution of common stock of the Issuer for no consideration by VV VI GP-GP.

Issuer

Aligos Therapeutics, Inc.

CIK 0001799448

Entity typeother

Related Parties

1
  • filerCIK 0001619294

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:43 PM ET
Size
17.0 KB